Data / Form D filings / ELUTE, INC.
ELUTE, INC.: Form D filing
ELUTE, INC., a pharmaceuticals company in Salt Lake City, UT, filed a Form D with the SEC in 2016. The latest, on March 31, 2016, reports $1.6 million sold of a $4.8 million offering to 13 investors.
Find out what ELUTE, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 417 WAKARA WAY, SUITE 3510, Salt Lake City, UT, 84108
- Phone
- (801) 583-5100
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2011
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1670751
The full lists. Form D filings in Utah: 660 rows, $33, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 31, 2016 | New notice | $4,800,000 | $1,635,000 | $3,165,000 | 13 | Mar 23, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Philip A. Davidson | Director | |
| David W. Grainger | Executive Officer, Director | |
| Dennis B. Farrar | Executive Officer, Director | |
| Stephanie L. Sorensen | Executive Officer | |
| Cheryl R. Blanchard | Director | |
| Ashok C. Khandkar | Executive Officer, Director | |
| Daniel P. Liston | Executive Officer | |
| Kristofer D. Sinclair | Executive Officer | |
| Kirk P. Andriano | Executive Officer, Director |
Every Form D from the week of Mar 28, 2016 · All recent filings in Utah · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ELUTE, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.